Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
BÀI TỔNG QUAN Issue: Số 107S TIM MẠCH CAN THIỆP

Some highlights in the field of peripheral vascular interventions in 2023

Đinh Huỳnh Linh: Trường Đại học Y Hà Nội; Nguyễn Tuấn Hải: Trường Đại học Y Hà Nội; Tạ Mạnh Cường: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai;
Published: January 20, 2024
Views: 6

Abstract

In 2023, there are some new studies in the field of peripheral vascular interventions. The Cardiology journal would like to highlight 2 points that could lead to changes in clinical practice

Keywords
The Cardiology journal

References

1.
Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41(4):522-529. doi:10.1093/eurheartj/ehz236
2.
Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405
3.
Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605-614. doi:10.1093/eurheartj/ehu218
4.
Toma C, Jaber WA, Weinberg MD, et al. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention. 2023;18(14):1201-1212. doi:10.4244/EIJ-D-22-00732
5.
Katsanos K, Spiliopoulos S, Kitrou P, et al. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7(24):e011245. doi:10.1161/JAHA.118.011245
6.
Nordanstig J, James S, Andersson M, et al. Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. N Engl J Med. 2020;383(26):2538-2546. doi:10.1056/NEJMoa2005206
7.
Secemsky EA, Song Y, Schermerhorn M, et al. Update From the Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study. Circ Cardiovasc Interv. 2022;15(6):e012074. doi:10.1161/CIRCINTERVENTIONS.122.012074
8.
Mao J, Sedrakyan A, Goodney PP, et al. Editor's Choice - Real World Study of Mortality After the Use of Paclitaxel Coated Devices in Peripheral Vascular Intervention. Eur J Vasc Endovasc Surg. 2023;65(1):131-140. doi:10.1016/j.ejvs.2022.08.014
9.
Liistro F, Reccia MR, Angioli P, et al. Drug-Eluting Balloon for Below the Knee Angioplasty: Five-Year Outcome of the DEBATE-BTK Randomized Clinical Trial. Cardiovasc Intervent Radiol. 2022;45(6):761-769. doi:10.1007/s00270-022-03104-3
Some highlights in the field of peripheral vascular interventions in 2023

Files

Article Views6
Document Views0
Downloads0
Section BÀI TỔNG QUAN
Issue Số 107S
Category TIM MẠCH CAN THIỆP
Pages 83-86
Copyright Holder 2024 Tạp chí Tim mạch học Việt Nam